SpringWorks

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch SpringWorks and buy or sell other stocks, ETFs, and their options commission-free!

About SWTX

Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines. Its pipeline includes Nirogacestat, Mirdametinib, Brimarafenib, SW-682, and EGFR Inhibitor. 

CEO
Saqib Islam
CEOSaqib Islam
Employees
368
Employees368
Headquarters
Stamford, Connecticut
HeadquartersStamford, Connecticut
Founded
2017
Founded2017
Employees
368
Employees368

SWTX Key Statistics

Market cap
3.54B
Market cap3.54B
Price-Earnings ratio
-13.78
Price-Earnings ratio-13.78
Dividend yield
Dividend yield
Average volume
5.26M
Average volume5.26M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$62.00
52 Week high$62.00
52 Week low
$28.21
52 Week low$28.21

People also own

Based on the portfolios of people who own SWTX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.